Following publication, the publisher has uncovered conclusive evidence that a false identity was used as a peer reviewer for this article. This reviewer was not suggested by the authors. This peer reviewer has now been removed.
This article is currently under post publication assessment. This expression of concern has been posted while Frontiers awaits the outcome of this assessment and will then be updated accordingly.
Summary
Keywords
AMPKα2, cardiomyocytes, ischemia-reperfusion injury, mitochondrial dynamics, Sirt3/PGC1α signaling pathway
Citation
Frontiers Editorial Office (2022) Expression of Concern: AMPKα2 overexpression reduces cardiomyocyte ischemia-reperfusion injury through normalization of mitochondrial dynamics. Front. Cell Dev. Biol. 10:1014325. doi: 10.3389/fcell.2022.1014325
Received
08 August 2022
Accepted
08 August 2022
Published
23 August 2022
Approved by
Volume
10 - 2022
Updates
Copyright
© 2022 .
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org
This article was submitted to Mitochondrial Research, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.